INTRODUCTION
Heterocyclic compounds are promising agents in the development of synthetic molecules with bioactivity. Fused heterocyclic structures containing pyrimidine or furan rings exhibited diverse biological activities such as antimicrobial, anti-inflammatory, antiviral and anticancer. 1 The furo [2,3-d] pyrimidines, which are an important class of heterocyclic compounds, have been considered for many years as a model for the discovery of drugs for inhibition of the enzyme dihydrofolate reductase (DHFR). 2 In view of this biological activity, the objective of this work consists on the synthesis of new furo [2,3-d] pyrimidines as potential agents to act as antifolates inhibiting DHFR, which is present in various fungi, bacteria and protozoa. These compounds may be new agents for neglected diseases.
RESULTS AND DISCUSSION
The methodology for the synthesis furo [2,3-d] pyrimidine derivatives (5) consists of 2 steps as shown in Figure 1 . The first step consists on the synthesis of benzylidene barbiturate (3) through of the Knoevenagel condensation reaction between of aromatic aldehyde (1) and the barbituric acid (2) at room temperature for 40 min. In the second step, the furo [2,3-d] pyrimidine was formed by reaction of the benzylidene barbiturate with cyclohexyl isonitrile (4) in dry dioxane under reflux for 3h. 
CONCLUSION
This new developed method for preparation of furo [2,3-d] pyrimidines is only effective on less polarized benzylidene barbiturates, a process that requires the presence of electronic attractive groups on the aromatic ring. These furo [2,3-d] pyrimidine derivatives (5a and 5b) and others that are synthesized will be evaluated biologically for inhibition the enzyme DHFR.
